TheraJect, Inc.
Reinventing Rare Earth Innovation with AI
From Materials Discovery to Sustainable Extraction and Supply-Chain Intelligence
TheraJect is building an AI-driven platform for the rare-earth ecosystem, integrating materials discovery, biomining, and digital twin supply-chain intelligence to enable secure, sustainable, and resilient critical-material systems.
Critical Materials Are the Bottleneck of the Future
Rare-earth elements power:
- Electric vehicles
- Wind turbines
- Semiconductors
- Defense systems
Yet global supply chains remain:
- Geopolitically concentrated
- Environmentally intensive
- Technologically fragmented
TheraJect addresses this challenge end-to-end using AI.
Our Platform
TheraJect’s platform is built on three core pillars:
1️⃣ AI-Driven Materials Discovery
We develop next-generation rare-earth materials using:
- Generative AI models (VAE, diffusion, GFlowNet)
- Graph neural networks and transformer architectures
- Structure generation and surrogate property prediction (e.g., M3GNet)
- High-throughput DFT validation
- Multi-objective optimization for magnetics, stability, cost, and manufacturability
Applications include permanent magnets, photonic materials, semiconductors, and advanced battery systems.
2️⃣ AI-Guided Bio-Extraction (Biomining)
TheraJect is advancing sustainable rare-earth recovery through:
- Lanmodulin-based selective REE binding
- Protein language models (ESM-2) for sequence representation
- Machine learning prediction of selectivity and performance
- Immobilization and support-material optimization
- Low-impact and energy-efficient extraction technologies
3️⃣ Digital Twin & Supply-Chain Intelligence
We develop AI-enabled digital twins of rare-earth systems to:
- Simulate supply chains from extraction to deployment
- Model extraction, separation, and recycling processes
- Analyze geopolitical and policy-driven scenarios
- Optimize cost, resilience, and resource flow
Technology Foundation
TheraJect integrates:
- Generative AI for materials and molecular design
- Physics-informed modeling and quantum simulation (DFT)
- Protein machine learning for biomining applications
- Data fusion across materials, biological, and industrial datasets
- Multi-objective optimization across performance, cost, and sustainability
Strategic Focus
Our platform supports:
- U.S. national priorities in critical minerals, clean energy, and semiconductor manufacturing (CHIPS & IRA)
- Allied innovation ecosystems, including Korea, Japan, and Europe
- Development of next-generation REE materials and sustainable extraction technologies
Global Innovation Bridge
TheraJect is building a U.S.–Korea strategic innovation bridge, enabling international collaboration and investment while maintaining U.S.-executed programs, IP control, and regulatory compliance.
Company
TheraJect TheraJect is a Silicon Valley–based, founder-led company developing AI-driven infrastructure for critical materials innovation.
Originally founded in biotechnology, TheraJect previously developed dissolving microneedle technologies supported by:
- NIH
- NSF
- Bill & Melinda Gates Foundation
This technology was successfully licensed for commercialization.
Today, TheraJect applies that innovation foundation to AI-driven materials and industrial systems.